Virios Therapeutics Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Go back to Virios Therapeutics Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Virios Therapeutics (VIRI) Reports Q2 Loss of $0.51/sh

August 12, 2021 7:22 AM EDT

Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.51), versus ($0.14) reported last year.

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

... More